David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Strategic Education
STRA
$1.89B
| $675K | ﹤0.01% |
5,139
-2,005
| -28% | -$244K |
|
2802
Universal Corp
UVV
$1.16B
| $673K | ﹤0.01% |
11,676
-38,752
| -77% | -$2.23M |
|
2803
Ennis
EBF
$543M
| $670K | ﹤0.01% |
32,267
-19,344
| -37% | -$398K |
|
|
GHL
2804
DELISTED
Greenhill & Co., Inc.
GHL
| $667K | ﹤0.01% |
31,023
+331
| +1% | +$8.22K |
|
|
SIEN
2805
DELISTED
Sientra, Inc.
SIEN
| $664K | ﹤0.01% |
+7,743
| New | +$867K |
|
2806
Addus HomeCare
ADUS
$2.25B
| $659K | ﹤0.01% |
10,363
-6,636
| -39% | -$427K |
|
2807
PUT
Yelp
YELP
$1.23B
| $659K | ﹤0.01% |
+19,100
| New | +$691K |
|
|
PFC
2808
DELISTED
Premier Financial Corp. Common Stock
PFC
| $657K | ﹤0.01% |
22,849
+7,476
| +49% | +$216K |
|
|
ACB
2809
Aurora Cannabis
ACB
$253M
| $656K | ﹤0.01% |
604
-17,003
| -97% | -$15.2M |
|
2810
Lakeland Financial Corp
LKFN
$1.48B
| $655K | ﹤0.01% |
14,500
-9,667
| -40% | -$441K |
|
2811
Titan Machinery
TITN
$438M
| $653K | ﹤0.01% |
41,993
-67,682
| -62% | -$1.25M |
|
2812
Parker-Hannifin
PH
$131B
| $652K | ﹤0.01% |
3,800
-10,296
| -73% | -$1.71M |
|
2813
CALL
Match Group
MTCH
$9.66B
| $651K | ﹤0.01% |
11,500
+5,200
| +83% | +$275K |
|
|
CHK
2814
CALL
DELISTED
Chesapeake Energy Corporation
CHK
| $651K | ﹤0.01% |
1,050
-35
| -3% | -$19.6K |
|
2815
Hormel Foods
HRL
$13B
| $650K | ﹤0.01% |
14,518
-29,472
| -67% | -$1.26M |
|
2816
Wendy's
WEN
$1.72B
| $649K | ﹤0.01% |
36,288
-923,439
| -96% | -$15.7M |
|
2817
PUT
Allegiant Air
ALGT
$2.26B
| $647K | ﹤0.01% |
5,000
-15,000
| -75% | -$1.91M |
|
2818
Culp Inc
CULP
$43.6M
| $646K | ﹤0.01% |
33,600
+6,925
| +26% | +$129K |
|
|
NAV
2819
CALL
DELISTED
Navistar International
NAV
| $646K | ﹤0.01% |
20,000
| – | – |
|
|
NAV
2820
PUT
DELISTED
Navistar International
NAV
| $646K | ﹤0.01% |
20,000
| – | – |
|
|
NE
2821
DELISTED
Noble Corporation
NE
| $645K | ﹤0.01% |
224,590
-813,735
| -78% | -$2.53M |
|
2822
Goosehead Insurance
GSHD
$2.53B
| $644K | ﹤0.01% |
+23,089
| New | +$661K |
|
2823
CALL
M&T Bank
MTB
$34.9B
| $644K | ﹤0.01% |
+4,100
| New | +$673K |
|
2824
PUT
Fastenal
FAST
$58.7B
| $643K | ﹤0.01% |
+40,000
| New | +$602K |
|
2825
National Bank Holdings
NBHC
$1.84B
| $643K | ﹤0.01% |
19,320
-21,036
| -52% | -$704K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.